Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023 Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted ...

Concepts announced the limited market release of the Nanoplasty 3D Minimally Invasive, MIS, Bunion Correction System and ...

With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.

The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...